
VIR vs MESO
$VIR vs $MESO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
VIR vs MESO: trend, levels and the market
One year to 2026-11-18, against the S&P 500 (+10.6%). Split-adjusted daily closes.
- ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
- ·Only VIR beat the market over the past year, by 55.7%, while MESO trailed the S&P 500 at +10.6% by 32.4%.
- ·The last month has flipped the order: MESO has held up better over the month (-6.2% against -14.8%) even though VIR leads over the year.
- ·VIR has support 33.6% below at $6.24; MESO has no tested support within 35% under its price.
- ·VIR is within 2% of resistance at $9.58, a price where it has stalled before.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
VIR vs MESO: the quick read
- ·VIR is the larger company by market cap ($1.58B vs $1.55B).
- ·VIR has been more active on our scanner (161 vs 62 alerts in 30 days).
- ·MESO has the smaller float (129.9M vs 154.7M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) vs Biological Products, (No Diagnostic Substances)), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 161 and 62 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 2% of each other on market cap, which makes the rest of this table the interesting part.
- ·VIR pays a dividend and MESO does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Watching VIR or MESO? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing VIR and MESO on TheDesperateTrader.
- Is VIR or MESO the better stock?
- "Better" depends on your goal, and these two are not alike. VIR is the larger company by market cap ($1.58B vs $1.55B). VIR has been more active on our scanner (161 vs 62 alerts in 30 days). MESO has the smaller float (129.9M vs 154.7M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between VIR and MESO?
- The differences that matter: they are not in the same business - VIR is biological products, (no diagnostic substances) and MESO is biological products, (no diagnostic substances); they are similar in size ($1.58B vs $1.55B); they trade at very different share prices ($9.39 vs $11.64); VIR sits at 45% of its 52-week range against -1% for MESO; only VIR pays a dividend; our scanner flagged VIR 161 times in the last 30 days against 62 for MESO. Everything above is measured from the latest completed session and SEC filings.
- Which of VIR and MESO is more active right now?
- Right now VIR is at about 1.3x its normal volume and MESO is at about 1.0x, so VIR is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is VIR or MESO in the stronger trend?
- VIR is below its 50-day average of $11.04 and below its 200-day average of $9.79; MESO is below its 50-day average of $14.04 and below its 200-day average of $15.13. VIR leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading VIR or MESO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore VIR and MESO comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.